Cervical Cancer Vaccine Mount Kisco NY

The human papillomavirus (HPV) vaccine works for women aged 24 to 45 in Mount Kisco who aren't already infected by HPV, the virus that has been linked to cervical cancer and other cervical diseases. That's the finding from Dr. Nubia Munoz, of the National Institute of Cancer in Bogota, Columbia, who noted that women's rising age at first marriage and increasing divorce rates have led to more widespread premarital intercourse and pairing with new sexual partners around middle age.

Local Companies

MARC ZIMMERMAN, MD
(845) 362-3970
974 Rte 45
Pomona, NY
Sheryl Lynn Leventhal, MD
914-362-1750
500 New Hempstead Rd Ste C
New City, NY
Robert Jay Schneider, MD
914-666-8976
101 Bedford Rd
Mount Kisco, NY
Martin Barry Abrams, MD
203-792-5303
16 Hospital Ave Ste 102
Danbury, CT
Lawrence Eugene Posner, MD
203-622-0117
633 Round Hill Rd
Greenwich, CT
Salvatore Anthony Delprete
(203) 325-2695
34 Shelburne Road
Stamford, CT
Asim Aijaz, MD
914-493-8374
12 Reeback Dr
Valhalla, NY
Alex N Helper, MD
845-735-4061
1 Old Middletown Rd
Pearl River, NY
Michael Henry Bar, MD
203-325-2695
34 Shelburne Rd
Stamford, CT
John Francis Pezzimenti, MD
203-797-7029
95 Locust Ave
Danbury, CT
Data Provided by:
    

Provided By:

TUESDAY, June 2 (HealthDay News) -- The human papillomavirus (HPV) vaccine works for women aged 24 to 45 who aren't already infected by HPV, the virus that has been linked to cervical cancer and other cervical diseases.

That's the finding from Dr. Nubia Munoz, of the National Institute of Cancer in Bogota, Columbia, who noted that women's rising age at first marriage and increasing divorce rates have led to more widespread premarital intercourse and pairing with new sexual partners around middle age.

Their study included more than 3,200 women, aged 24 to 45, with no history of cervical disease or cancer or genital warts caused by HPV types 6, 11, 16 and 18. The women received either the quadrivalent HPV vaccine, which protects against the four HPV types, or a placebo at day one and months two and six of the study.

The women were followed for about 2.2 years and the researchers identified four cases of infection or disease in the vaccinated group, compared to 41 cases in the placebo group. That means the vaccine was 91 percent effective against all four virus strains.

When they looked at only HPV types 16 and 18, the researchers found four cases in the vaccine group and 23 in the placebo group, which means the vaccine was 83 percent effective against those two HPV types.

"Lower effectiveness detected in the mixed population (susceptible women and those who have already acquired HPV infection or HPV-associated disease) suggests that the public health effect of vaccinating women aged 25 to 45 years will be smaller than that recorded after vaccinating susceptible adolescents. This notion will be assessed in future cost-benefit analyses," the study authors wrote.

The findings appear online June 2 and in an upcoming print issue of The Lancet.

More information

The U.S. National Cancer Institute has more about HPV vaccines.

SOURCE: The Lancet, news release, June 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Risks for Childhood Cancer Survivors Mount Kisco NY
People who survived cancer as children face a high lifelong risk for developing another cancer, a new study has found. A study that appears online May 26 in the Journal of the National Cancer Institute went further than earlier studies by following people from birth through age 79. The researchers analyzed data on more than 47,000 people who had been diagnosed with cancer before the age of 20.
- Delayed Prostate Cancer Therapy Mount Kisco NY
- Folic Acid Preventing Breast Cancer Mount Kisco NY
- Fertility in Ovarian Cancer Patients Mount Kisco NY
- HPV and Cervical Cancer Mount Kisco NY
- Exercise for Prostate Cancer Mount Kisco NY
- Breast Cancer Treatment Mount Kisco NY
- Colon Cancer Prevention Mount Kisco NY
- Follow Up After Skin Cancer Mount Kisco NY